Home
Live Updates
Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q1 2022 Results - Earnings Call Transcript : comparemela.com
Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q1 2022 Results - Earnings Call Transcript
Neurocrine Biosciences, Inc. (NASDAQ:NASDAQ:NBIX) Q1 2022 Earnings Conference Call May 04, 2022, 08:00 ET Company Participants Todd Tushla - VP, IR Kevin Gorman - CEO & Director Matthew...
Related Keywords
Japan ,
United States ,
Russia ,
Ukraine ,
Japanese ,
American ,
Todd Tushla ,
Raymond James ,
Chris Shibutani ,
Kyle Gano ,
Josh Schimmer ,
Laura Chico ,
Mandy Parkinson ,
Joshua Schimmer ,
Piper Sandler ,
Matthew Abernethy ,
Amy Roberts ,
Phil Nadeau ,
Eric Benevich ,
William Blair ,
Neena Bitritto Garg ,
Anupam Rama ,
Charles Duncan ,
Carter Gould ,
Marc Goodman ,
Paul Matteis ,
Matt Abernethy ,
Brian Abrahams ,
Amy Fadata ,
Jay Olson ,
Danielle Brill ,
America Merrill Lynch ,
Myles Minter ,
Brian Skorney ,
Yatin Suneja ,
Eiry Roberts ,
David Amsellem ,
Tazeen Ahmad ,
Philip Nadeau ,
Kevin Gorman ,
Morgan Stanley ,
Company Participants ,
Goldman Sachs ,
Nasdaq ,
Jpmorgan Chase Co ,
Cantor Fitzgerald ,
Nicolaus Company ,
Goldman Sachs Group ,
Robertw Baird Co ,
Barclays ,
Neurocrine Biosciences Inc ,
Barclays Bank ,
Cantor Fitzgerald Co ,
Mitsubishi Tanabe Pharma Corporation ,
William Blair Company ,
American Academy Of Neurology ,
Huntington Disease Study Group ,
Citigroup ,
Business Development ,
Serco ,
Neurocrine Biosciences ,
Conference Call May ,
America Merrill ,
Neurocrine Biosciences Reports First Quarter ,
Chief Executive Officer ,
Chief Financial Officer ,
Chief Medical Officer ,
Chief Commercial Officer ,
Chief Business Development ,
Chief Commercial ,
Tardive Dyskinesia Awareness ,
Chief Medical ,
Disease Study Group ,
American Academy ,
Unified Huntington ,
Disease Rating Scale ,
Total Maximal Chorea Score ,
What Serco ,
North America ,
Total Maximal Chorea ,
Vamil Divan ,
Jeff Hung ,
comparemela.com © 2020. All Rights Reserved.